Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Prophylactic respiratory physiotherapy after cardiac surgery: systematic review [with consumer summary]
Pasquina P, Tramer MR, Walder B
BMJ 2003 Dec 13;327(7428):1379-1384
systematic review

OBJECTIVE: To assess whether respiratory physiotherapy prevents pulmonary complications after cardiac surgery. DATA SOURCES: Searches through Medline, Embase, CINAHL, the Cochrane Library, and bibliographies, for randomised trials comparing any type of prophylactic respiratory physiotherapy with another type or no intervention after cardiac surgery, with a follow up of at least two days, and reporting on respiratory outcomes. REVIEW METHODS: Investigators assessed trial validity independently. Information on study design, population, interventions, and end points was abstracted by one investigator and checked by the others. RESULTS: 18 trials (1,457 patients) were identified. Most were of low quality. They tested physical therapy (13 trials), incentive spirometry (eight), continuous positive airway pressure (five), and intermittent positive pressure breathing (three). The maximum follow up was six days. Four trials only had a no intervention control; none showed any significant benefit of physiotherapy. Across all trials and interventions, average values postoperatively were: incidence of atelectasis, 15 to 98%; incidence of pneumonia, 0 to 20%; partial pressure of arterial oxygen per inspired oxygen fraction, 212 to 329 mmHg; vital capacity, 37 to 72% of preoperative values; and forced expiratory volume in one second, 34 to 72%. No intervention showed superiority for any end point. For the most labour intensive intervention, continuous positive airway pressure, the average cost of labour for each patient day was Euro 27 (Great British Pounds 19; $32). CONCLUSIONS: The usefulness of respiratory physiotherapy for the prevention of pulmonary complications after cardiac surgery remains unproved. Large randomised trials are needed with no intervention controls, clinically relevant end points, and reasonable follow up periods.
Reproduced with permission from the BMJ Publishing Group.

Full text (sometimes free) may be available at these link(s):      help

A brief summary and a critical assessment of this review may be available at DARE